TREATMENT OF DESTRUCTIVE DISORDERS OF CORNEAL EPITHELIUM IN EYES WITH DRY EYE SYNDROME

Authors

  • S.О. Rykov National Medical Academy of Postgraduate Education named after P. L. Shupyk of the Ministry of Public Health of Ukraine
  • N. S. Lavryk National Medical Academy of Postgraduate Education named after P. L. Shupyk of the Ministry of Public Health of Ukraine
  • O.V. Akimenko National Medical Academy of Postgraduate Education named after P. L. Shupyk of the Ministry of Public Health of Ukraine
  • L.P. Novak National Medical Academy of Postgraduate Education named after P. L. Shupyk of the Ministry of Public Health of Ukraine
  • L.V. Kornilov Kyiv City Clinical Ophthalmologic Hospital “Eye Microsurgery Center” of the Ministry of Public Health of Ukraine Kyiv, Ukraine

DOI:

https://doi.org/10.22141/2309-8147.4.1.2016.172885

Keywords:

cornea, dry eye syndrome-related destructive disorders of cornea, complex treatment, Tealoz Duo

Abstract

The results of the clinical examination of 16 patients (31 eyes) aged 29 to 72 years with dry eye syndrome – related destructive disorders of corneal epithelium.
Investigation of cornea condition was carried out for comparative analysis of clinical parameters after treatment with using of corneoprotector Tealoz Duo (Laboratories Thea). The application of Tealoz Duo signifi cantly improves clinical indicators of treatment of disease (confi rmed by biomicroscopy method (epithelisation of the cornea area), tests namely Shirmer’s and Norn’s (tear fi lm break up time).
Obtained results showed disturbance of moistening condition and reparation of the cornea after using corneoprotector Tealoz Duo during 30 days period in 50% cases.
Use of eye drops gaves increasing of the tear fi lm break up time (р < 0,05).
Treatment with the inclusion of Tealoz Duo shows the effectiveness of therapy dry eye syndrome - related destructive disorders of cornea during 14–30 days period (8,3 – 1,2 balls (р < 0,05)).

Downloads

Download data is not yet available.

Published

2016-02-01

Issue

Section

Ophthalmo-Pharmacological Therapy

Most read articles by the same author(s)